Last reviewed · How we verify

NCT07140770

Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation

Recruiting now Last updated 10 March 2026
What this trial tests

trial testing Fitbit in Physical Activity in 66 participants. Currently enrolling.

Timeline
2 September 2025
Primary endpoint
1 April 2026
1 April 2028

Quick facts

Lead sponsorM.D. Anderson Cancer Center
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment66
Start date2 September 2025
Primary completion1 April 2026
Estimated completion1 April 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

M.D. Anderson Cancer Center — full company profile →

Who can join

18 and older, any sex, with Physical Activity or Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To understand the changes in health-related quality of life of patients and caregivers after allogeneic hematopoietic cell transplantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fitbit

Trials testing the same drug.

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other M.D. Anderson Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07140770.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing